Abstract
A novel anticancer prodrug compound 1, which was designed to be triggered by thiols and release the chemotherapeutic agent mechlorethamine, was successfully prepared and evaluated for the first time. The activation of compound 1 was determined by NMR analysis and denaturing alkaline agarose gel electrophoresis. A fluorescence image and comet assay indicated that the inducible reactivity of 1 could be accomplished in cell media. The anticancer activities are also discussed.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / chemical synthesis
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology*
-
Cell Line, Tumor
-
Cell Proliferation / drug effects
-
Dose-Response Relationship, Drug
-
Drug Screening Assays, Antitumor
-
Humans
-
Mechlorethamine / chemical synthesis
-
Mechlorethamine / chemistry
-
Mechlorethamine / pharmacology
-
Molecular Structure
-
Prodrugs / chemical synthesis
-
Prodrugs / chemistry
-
Prodrugs / pharmacology*
-
Structure-Activity Relationship
-
Sulfhydryl Compounds / chemical synthesis
-
Sulfhydryl Compounds / chemistry
-
Sulfhydryl Compounds / pharmacology*
Substances
-
Antineoplastic Agents
-
Prodrugs
-
Sulfhydryl Compounds
-
Mechlorethamine